Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6850-6856

  Kisley, Lori R ^a   Barrett, Bradley S ^a   Bauer, Alison K ^c   Dwyer Nield, Lori D ^a   Barthel, Benjamin ^a   Meyer, Amy M ^a   Thompson, David C ^a   Malkinson, Alvin M ^b  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CRESOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; URETHAN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL GENETICS; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHRONIC INFLAMMATION; CLARA CELL; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; IMMUNOBLOTTING; LUNG ADENOCARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG CARCINOGENESIS; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WILD TYPE;

ANIMALS; BUTYLATED HYDROXYTOLUENE; CARCINOGENS; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; LUNG NEOPLASMS; LYMPHOKINES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; URETHANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036896004     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA Cancer J. Clin., 51: 15-36, 2001.
2. Gazdar, A. F., and Linnoila, R. I. The pathology of lung cancer-changing concepts and newer diagnostic techniques. Semin. Oncol., 15: 215-225. 1988.
3. nd Ed. pp. 602- 611. Philadelphia: Lippincott, Williams and Wilkins, 2000.
4. Carney, D. N. Lung cancer-time to move on from chemotherapy. N. Engl. J. Med., 346: 126-128, 2002.
5. Ahn, B., and Ohshima, H. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res., 61: 8357-8360, 2001.
6. Rao, C. V., Indranie, C., Simi, B., Manning, P. T., Connor, J. R., and Reddy, B. S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res., 62: 165-170, 2002.
7. Rao, C. V., Kawamori, T., Hamid, R., and Reddy, B. S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (Lond.), 20: 641-644, 1999.
8. Cuzzocrea, S., Mazzon, E., Calabro, G., Dugo, L., De Sarro, A., van De LOO, F. A., and Caputi, A. P. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am. J. Respir. Crit. Care Med., 162: 1859-1866, 2000.
9. Moilanen, E., Whittle, B., and Moncada, S. Nitric oxide as a factor in inflammation. In J. I. Gallin and R. Snyderman (eds.), Inflammation: Basic Principles and Clinical Correlates, 3rd Ed, pp. 787-800. Philadelphia: Lippincott, Williams and Wilkins, 1999.
10. Phillips, P. G., Birnby, L. M., Narendran, A., and Milonovich, W. L. Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface. Am. J. Physiol. Lung Cell Mol. Physiol., 281: L278-L290, 2001.
11. Liu, C. Y., Wang, C. H., Chen, T. C., Lin, H. C., Yu, C. T., and Kuo, H. P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer, 78: 534-541, 1998.
12. Fujimoto, H., Ando, Y., Yamashita, T., Terazaki, H., Tanaka, Y., Sasaki, J., Matsumoto, M., Suga, M., and Ando, M. Nitric oxide synthase activity in human lung cancer. Jpn. J. Cancer Res., 88: 1190-1198, 1997.
13. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res., 305: 253-264, 1994.
14. Liu, R. H., and Hotchkiss, J. H. Potential genotoxicity of chronically elevated nitric oxide: A review. Mutat. Res., 339: 73-89, 1995.
15. Lala, P. K., and Orucevic, A. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev., 17: 91-106, 1998.
16. Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A., and Ziche, M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst., 90: 587-596, 1998.
17. Parenti, A., Morbidelli, L., Cui, X. L., Douglas, J. G., Hood, J. D., Granger, H. J., Ledda, F., and Ziche, M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinasel/2 activation in postcapillary endothelium. J. Biol. Chem., 273: 4220-4226, 1998.
18. Jozkowicz, A., Cooke, J. P., Guevara, I., Huk, I., Funovics, P., Pachinger, O., Weidinger, F., and Dulak. J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc. Res., 51: 773-783. 2001.
19. Konopka, T. E., Barker, J. E., Bamford, T. L., Guida, E., Anderson, R. L., and Stewart, A. G. Nitric oxide synthase II gene disruption: Implications for tumor growth and vascular endothelial growth factor production. Cancer Res., 61: 3182-3187, 2001.
20. Kobzik, L., Bredt, D. S., Lowenstein, C. J., Drazen, J., Gaston, B., Sugarbaker, D., and Stamler, J. S. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol., 9: 371-377, 1993.
21. Bauer, A. K., Dwyer-Nield, L. D., Hankin, J. A., Murphy, R. C., and Malkinson, A. M. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology, 169: 1-15, 2001.
22. Bauer, A. K., Dwyer-Nield, L. D., Keil, K., Koski, K., and Malkinson, A. M. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp. Lung Res., 27: 197-216, 2001.
23. Malkinson, A. M. Primary lung tumors in mice: An experimentally manipulable model of human adenocarcinoma. Cancer Res., 52: 2670s-2676s, 1992.
24. Malkinson, A. M. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res., 24: 541-555, 1998.
25. Cohen, B. H., Diamond, E. L., Graves, C. G., Kreiss, P., Levy, D. A., Menkes, H. A., Permutt, S., Quaskey, S., and Tockman, M. S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet, 2: 523-526, 1977.
26. Malkinson, A. M., Radcliffe, R. A., and Bauer, A. K. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis (Lond.), 23: 411-417, 2002.
27. Bauer, A. K., Dwyer-Nield, L. D., and Malkinson, A. M. High cyclooxygenase I (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis (Lond.), 21: 543-550, 2000.
28. Marnett, L. J., Wright, T. L., Crews, B. C., Tannenbaumm, S. R., and Morrow, J. D. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J. Biol. Chem., 275: 13427-13430, 2000.
29. Salvemini, D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol. Life Sci., 53: 576-582, 1997.
30. Salvemini, D., Manning, P. T., Zweifel, B. S., Seibert, K., Connor, J., Currie, M. G., Needleman, P., and Masferrer, J. L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Investig., 96: 301-308, 1995.
31. Laubach, V. E., Shesely, E. G., Smithies, O., and Sherman, P. A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA, 92: 10688-10692, 1995.
32. Malkinson, A. M., and Beer, D. S. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl. Cancer Inst., 70: 931-936, 1983.
33. Malkinson, A. M., Miley, F. B., Chichester, C. H., and Plopper, C. G. Isolation of nonciliated bronchiolar (Clara) epithelial cells from mouse lung. Methods Toxicol., 1A: 123-133, 1993.
34. Thaete, L. G., and Malkinson, A. M. Cells of origin of primary pulmonary neoplasms in mice: Morphologic and histochemical studies. Exp. Lung Res., 17: 219-228, 1991.
35. Guo, F. H., De Raeve, H. R., Rice, T. W., Stuehr, D. J., Thunnissen, F. B., and Erzurum, S. C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA, 92: 7809-7813, 1995.
36. Sherman, T. S., Chen, Z., Yuhanna, I. S., Lau, K. S., Margraf, L. R., and Shaul, P. W. Nitric oxide synthase isoform expression in the developing lung epithelium. Am. J. Physiol, 276: L383-L390, 1999.
37. Miles, P. R., Bowman, L., Rengasamy, A., and Huffman, L. Constitutive nitric oxide production by rat alveolar macrophages. Am. J. Physiol, 274: L360-L368, 1998.
38. Asano, K., Chee, C. B., Gaston, B., Lilly, C. M., Gerard, C., Drazen, J. M., and Stamler, J. S. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA. 91: 10089-10093, 1994.
39. Schmidt, H. H., Gagne, G. D., Nakane, M., Pollock, J. S., Miller, M. F., and Murad, F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J. Histochem. Cytochem., 40: 1439-1456, 1992.
40. Ferrara, N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res., 55: 15-35, 2000.
41. Yuan, A., Yu, C. J., Chen, W. J., Lin, F. Y., Kuo, S. H., Luh, K. T., and Yang, P. C. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int. J. Cancer, 89: 475-483, 2000.
42. Dachs, G. U., and Tozer, G. M. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer, 36: 1649-1660, 2000.
43. Kubes, P., and Granger, D. N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262: H611-H615, 1992.
44. Shi, Q., Xiong, Q., Wang, B., Le, X., Khan, N. A., and Xie, K. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res., 60: 2579-2583, 2000.
45. Wang, B., Xiong, Q., Shi, Q., Tan, D., Le, X., and Xie, K. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer, 91: 607-611, 2001.
46. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396. 1995.
47. Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., and Ahmed, A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol., 159: 993-1008, 2001.
48. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., and Bicknell, R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Investig., 99: 2625-2634, 1997.
49. Li, D., Laubach, V. E., and Johns, R. A. Upregulation of lung soluble guanylate cyclase during chronic hypoxia is prevented by deletion of eNOS. Am. J. Physiol. Lung Cell Mol. Physiol., 281: L369-L376, 2001.
50. Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C. O., Buerk, D. G., Huang, P. L., and Jain, R. K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci, USA, 98: 2604-2609, 2001.
51. Scott, D. J., Hull, M. A., Cartwright, E. J., Lam, W. K., Tisbury, A., Poulsom, R., Markham, A. F., Bonifer, C., and Coletta, P. L. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology, 121: 889-899, 2001.
52. Reddy, B. S., Hirose, Y., Lubet, R., Steele, V., Kelloff. G., Paulson, S., Seibert, K., and Rao, C. V. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res., 60: 293-297, 2000.
53. Marrogi, A. J., Travis, W. D., Welsh, J. A., Khan, M. A., Rahim, H., Tazelaar, H., Pairolero, P., Trastek, V., Jett, J., Caporaso, N. E., Liotta, L. A., and Harris, C. C. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res., 6: 4739-4744, 2000.
54. Sautebin, L., and Di Rosa, M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur. J. Pharmacol., 262: 193-196. 1994.
55. Malkinson, A. M., Koski, K. M., Dwyer-Nield, L. D., Rice, P. L., Rioux, N., Castonguay, A., Ahnen, D. J., Thompson, H., Pamukcu, R., and Piazza, G. A. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis (Lond,), 19: 1353-1356, 1998.
56. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Steele, V. E., and Kelloff, G. J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res., 57: 5489-5492, 1997.
57. Keith, R, L., Miller, Y. E., Hoshikawa, Y., Moore, M. D., Gesell, T. L., Gao, B., Malkinson, A. M., Golpon, H. A., Nemenoff, R. A., and Geraci, M. W. Prostacyclin sythase overexpression prevents mouse lung carcinogenesis. Cancer Res., 62: 734-740, 2002.
58. Soh, J. W., Mao, Y., Kim, M. G., Pamukcu, R., Li, H., Piazza, G. A., Thompson, W. J., and Weinstein, I. B. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin. Cancer Res., 6: 4136-4141, 2000.
59. Liu, L., Li, H., Underwood, T., Lloyd, M., David, M., Sperl, G., Pamukcu, R., and Thompson, W. J. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J. Pharmacol. Exp. Ther., 299: 583-592, 2001.
60. Saleh, D., Ernst, P., Lim, S., Barnes, P. J., and Giaid, A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid. FASEB J., 12: 929-937, 1998.